---
title: "JDCMOLY's controlling shareholder completed the increase of 10.1015 million shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236020062.md"
description: "According to the Zhitong Finance APP, JDCMOLY announced that its controlling shareholder, Jinduicheng Molybdenum Industry Group Co., Ltd. (referred to as \"JDCM Group\"), has cumulatively increased its holdings in the company by 10.1015 million shares, accounting for 0.3131% of the company's total share capital, with an increase amount of 99.90058 million yuan. This increase plan has been completed"
datetime: "2025-04-15T09:58:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236020062.md)
  - [en](https://longbridge.com/en/news/236020062.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236020062.md)
generator: "portal-rs"
---

# JDCMOLY's controlling shareholder completed the increase of 10.1015 million shares

According to the Zhitong Finance APP, JDCMOLY (601958.SH) announced that its controlling shareholder, Jinduicheng Molybdenum Industry Group Co., Ltd. (referred to as "JDCM Group"), has cumulatively increased its holdings in the company by 10.1015 million shares, accounting for 0.3131% of the company's total share capital, with an increase amount of 99.90058 million yuan. This increase plan has been completed

### Related Stocks

- [601958.CN](https://longbridge.com/en/quote/601958.CN.md)

## Related News & Research

- [Rainier Acquisition director Jonas Grossman acquires $56,250 in common shares](https://longbridge.com/en/news/297826326.md)
- [CLS sets private placement of 259,208 units at SEK 7.6 each to Vator Securities](https://longbridge.com/en/news/297947534.md)
- [CLS issues 777,624 warrants in directed placement at SEK 1.9 exercise price](https://longbridge.com/en/news/297947522.md)
- [Outdoor Holding Company announces annual shareholder meeting](https://longbridge.com/en/news/297958057.md)
- [Oruka Therapeutics CEO Lawrence Klein sells USD 6.85 million in common shares](https://longbridge.com/en/news/297705054.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**